SEC Form 4 · accession 0001209191-15-072461
Alaunos Therapeutics, Inc. · TCRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Tarriff
Director
Period of report
Sep 25, 2015
Accepted (ET)
Sep 29, 2015 · 4:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 25, 2015 | A | 4,186 | $0.00 | A | 4,186 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F14,186 shares shall vest on 12/31/2015.